Ceedar Pharmaceuticals Private Limited
About Ceedar Pharmaceuticals Private Limited
Data last updated:
Ceedar Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. The company operates in the trade sector. It was incorporated on 26 October 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74899UP1993PTC120384. Its GSTIN is 09AABCC9512D1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Anil Kumar Kapoor and Mamta Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 126/56 Block G Govind Nagar, Kanpur, Uttar Pradesh, India – 208006.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.63 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹15,226 (net margin 0.6%) and EBITDA of ₹5.08 Lakh (EBITDA margin 18.4%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Ceedar Pharmaceuticals has one previous CIN (Corporate Identification Number): U74899DL1993PTC055807. The current CIN is U74899UP1993PTC120384, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899UP1993PTC120384 | Current |
| U74899DL1993PTC055807 | Previous |
Contact details
Ceedar Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address126/56 Block G Govind Nagar, Kanpur, Uttar Pradesh, India – 208006
To see the full contact details of Ceedar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ceedar Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ceedar Pharmaceuticals Private Limited, buy the company report.
Financials of Ceedar Pharmaceuticals Private Limited
FY 2025 filings availableCeedar Pharmaceuticals Private Limited reported revenue of ₹27.63 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 14% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,226 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ceedar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ceedar Pharmaceuticals Private Limited
Ceedar Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Kapoor | Director | 26 Oct 1993 | 33 Years 0 Months | Current |
| Mamta Kapoor | Director | 26 Oct 1993 | 33 Years 0 Months | Current |
Peer comparison
Ceedar Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tangible Pharmaceuticals Private Limited | ₹27.89 Lakh (FY 2025) | -30.0% | Mirzapur, Uttar Pradesh, India | |||
| Neptune Pharmaceuticals Private Limited | ₹27.79 Lakh (FY 2025) | 28.0% | Srinagar, Jammu and Kashmir, India | |||
| Rank Pharmaceuticals Limited | ₹27.73 Lakh (FY 2025) | Delhi, India | ||||
| Samvee Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2022) | 5.0% | Hyderabad, Telangana, India | |||
| Ceedar Pharmaceuticals Private Limitedthis company | ₹27.63 Lakh (FY 2025) | ₹15,226 | 0.6% | -14.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Ceedar Pharmaceuticals Private Limited, buy the company report.
Auditor
Ceedar Pharmaceuticals Private Limited is audited by SUNIL ABBI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL ABBI & ASSOCIATES | FY 2017 | 010949N |
Shareholding
The shareholding of Ceedar Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ceedar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ceedar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ceedar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ceedar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCC9512D1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ceedar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ceedar Pharmaceuticals Private Limited has 5 board changes on record since 1993: 2 appointments and 3 cessations. The latest: Varsha Kapoor ceased to be Director on 28 Jan 2016.
Frequently asked questions
Ceedar Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in the trade industry. It was incorporated on 26 October 1993 (33+ years old) and is registered under CIN U74899UP1993PTC120384.
Ceedar Pharmaceuticals has 2 current directors:
- Anil Kumar Kapoor - Director
- Mamta Kapoor - Director
The latest financial statements of Ceedar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ceedar Pharmaceuticals is 09AABCC9512D1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ceedar Pharmaceuticals is U74899UP1993PTC120384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceedar Pharmaceuticals was incorporated on 26 October 1993, making it 33+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ceedar Pharmaceuticals by revenue are Tangible Pharmaceuticals Private Limited, Neptune Pharmaceuticals Private Limited, Rank Pharmaceuticals Limited, Samvee Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Varsha Kapoor ceased to be Director on 28 Jan 2016. Bindu Dhingra ceased to be Director on 23 Nov 2009. Manpreet Dhingra ceased to be Director on 23 Nov 2009. Ceedar Pharmaceuticals has 5 board changes on record in total.
The registered office of Ceedar Pharmaceuticals is at 12656 Block G Govind Nagar, Kanpur, Uttar Pradesh, India – 208006.
Ceedar Pharmaceuticals operates in the trade industry.
The compliance status of Ceedar Pharmaceuticals is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.